Granlund, David () (The Swedish Retail Institute (HUI))
Abstract
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a panel of all pharmaceutical product sold in Sweden in 1997--2007. The price reduction due to the reform was estimated to average 10% and was found to be significantly larger for brand name pharmaceuticals than for generics. The results also imply that the reform amplified the effect of generic entry has on brand-name prices by a factor of ten. Results of a demand-estimation imply that the price reductions increased total pharmaceutical consumption by 8% and consumer welfare by SEK 2.7 billion annually.
Download Info
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page
whether it is in fact available.
3. Perform a search for a similarly titled item that would be
available.
Publisher Info
Paper provided by The Swedish Retail Institute (HUI) in its series HUI Working Papers with number
21.
Length: 29 pages Date of creation: 07 Apr 2009 Date of revision: Handle: RePEc:hhs:huiwps:0021
Contact details of provider: Postal: The Swedish Retail Institute (HUI), Regeringsgatan 60, 103 29 Stockholm, Sweden Phone: +46 (0)8 762 72 80 Fax: +46 (0)8 679 76 06 Email: Web page: http://www.hui.se/ More information through EDIRC
For technical questions regarding this item, or to correct its listing, contact: (Linda Thunström).